A Trial of Tadalafil and Glycemic Traits

NCT01444651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Insulin Resistance
Glucose Intolerance
Obesity

Interventions

DRUG: Tadalafil
DRUG: Placebo

Sponsor

Thomas J. Wang, MD